Tolins M, Weir E K, Chesler E, Pierpont G L
J Am Coll Cardiol. 1984 Apr;3(4):1051-7. doi: 10.1016/s0735-1097(84)80366-6.
Beta-adrenergic blocking agents, nitrates and calcium channel antagonists are effective in treating angina pectoris, but much remains unknown about how they act in combination. Consequently, treadmill exercise was used to assess the relative efficacy of nifedipine or isosorbide dinitrate, or both, in 19 patients with stable angina receiving propranolol. Propranolol therapy was continued and either placebo, nifedipine (20 mg), isosorbide dinitrate (20 mg) or both drugs were given randomly 1 1/2 hours before exercise in a double-blind trial. In 16 patients who completed the protocol, heart rate at rest during propranolol therapy was 53.7 +/- 1.9 beats/min (mean +/- standard error of the mean); it increased 4.6 +/- 1.2 beats/min with the addition of nifedipine (p less than 0.01), but was unchanged with isosorbide dinitrate or both combined. Compared with values during treatment with propranolol alone, systolic blood pressure at rest decreased with each vasodilator individually and when combined. Rate-pressure product at maximal exercise was the same with all combinations. Exercise duration was 467 +/- 50 seconds with propranolol, increased to 556 +/- 47 seconds with isosorbide dinitrate (p less than 0.05) and to 636 +/- 50 seconds with nifedipine (p less than 0.001). Exercise duration with all three drugs was 597 +/- 47 seconds (p less than 0.01 compared with propranolol alone). The improvement with nifedipine was greater than with isosorbide dinitrate (p less than 0.05) but exercise duration was not significantly different with the combination of these drugs than when either drug was used alone.(ABSTRACT TRUNCATED AT 250 WORDS)
β-肾上腺素能阻滞剂、硝酸盐类和钙通道拮抗剂在治疗心绞痛方面有效,但它们联合使用时的作用机制仍有很多未知之处。因此,采用跑步机运动来评估硝苯地平或硝酸异山梨酯或两者联合应用于19例接受普萘洛尔治疗的稳定型心绞痛患者的相对疗效。在一项双盲试验中,继续给予普萘洛尔治疗,并在运动前1个半小时随机给予安慰剂、硝苯地平(20毫克)、硝酸异山梨酯(20毫克)或两种药物。在完成方案的16例患者中,普萘洛尔治疗期间静息心率为53.7±1.9次/分钟(平均值±平均标准误差);加用硝苯地平后心率增加4.6±1.2次/分钟(p<0.01),但硝酸异山梨酯或两者联合应用时心率无变化。与单独使用普萘洛尔治疗时的值相比,每种血管扩张剂单独使用及联合使用时静息收缩压均降低。最大运动时的心率-血压乘积在所有组合中相同。普萘洛尔治疗时运动持续时间为467±50秒,硝酸异山梨酯治疗时增加至556±47秒(p<0.05),硝苯地平治疗时增加至636±50秒(p<0.001)。三种药物联合使用时运动持续时间为597±47秒(与单独使用普萘洛尔相比p<0.01)。硝苯地平的改善效果大于硝酸异山梨酯(p<0.05),但这些药物联合使用时的运动持续时间与单独使用任一药物时相比无显著差异。(摘要截短至250字)